Cerebrovascular disease, a kind of common and frequently-occurring disease endangering the human health seriously, is one of the leading causes of death and disability worldwide, with the most frequent prevalence of ischemic cerebrovascular disease.1) Recanalization following ischemia is the most effective method for treatment of acute cerebral infarct and correction of hypoxia, but paradoxically causing severe cerebral ischemia-reperfusion (CI/R) injury. 2,3) Due to the lack of efficient neuroprotective therapies, the CI/R injury is still a major medical problem urgently needed to be further studied and discussed.A variety of cascade reactions induced by CI/R involve disequilibrium of calcium homeostasis, cytotoxicity of excitatory amino acid, oxidative stress, mitochondrial dysfunction, etc., [4][5][6] which has been accompanied by proteaseactivation and changing expression of genes, and ultimately resulting in neuron death and apoptosis. Increasing evidences suggest a critical role for oxidative stress in mediating tissue injury and neuron death during CI/R. 7,8) Brain is the most activated organ with aerobic metabolism, and produces a certain level of reactive oxygen species physiologically by aerobic metabolism, with a dynamic equilibrium of reactive oxygen species generation and elimination. Pathological unbalance occurs as the free radicals are produced excessively or endogenous anti-oxidative systems perform functional disturbance, and then, excessive accumulation of free radicals may induce oxidative reactions in attacked cells and tissues.9)The ability of free radicals production is greater than that of elimination by endogenous anti-oxidative systems in ischemic tissues especially in tissues after CI/R. 10) Elevated reactive oxygen species produced in cerebral ischemia could directly disrupt the structures of lipids, proteins and DNA, and induce cell death in various ways.11) Previous studies have well documented that increasing the activities of antioxidant enzymes, or administration of antioxidants, attenuates neuron damage during CI/R injury. [12][13][14] Conversely, lowering the antioxidant capacity increases neuron death after CI/R.
15)The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is a recently elucidated pathway to induce the production of antioxidant enzymes 16,17) -known as phase II enzymes including hemeoxygenase-1 (HO-1), reduced nicotinamide adenine dinucleotide phosphate (NADPH) quinone oxidoreductase 1, and g-glutamyl cysteine ligase (g-GCL)-through antioxidant-response element (ARE). Activating this way enhances the activities of those antioxidant enzymes and provides efficient cytoprotection, partly, by detoxifying reactive oxygen species and xenobiotics, regulating glutathione (GSH) production and use, and maintaining intracellular redox state. 18,19) Recent experiments have suggested that increasing the activity of Nrf2 and gene targets in cell culture models and stroke animal models that simulate components of cerebral ischemia damage is highly neuroprotective. 20,21...